“A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
, “Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.”, Bone Marrow Transplant, vol. 53, no. 1, pp. 64-68, 2018.
, “A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.”, Br J Ophthalmol, vol. 87, no. 1, pp. 28-31, 2003.
, “A multicenter randomized double-masked clinical trial of a new formulation of topical Cysteamine for the treatment of Corneal Cystine Crystals in cystinosis”, Brit J Ophthalmol, vol. 87, pp. 28-31, 2003.
, “Efficacy and Safety of Azithromycin versus Placebo to Treat Lower Respiratory Tract Infections Associated with Low Procalcitonin: a Randomised, Placebo-controlled, Double-blind, Non-inferiority Trial”, Lancet Infect Dis, vol. 23, no. 4, pp. 484-495, 2023.
, “Metabolic and monetary costs of avoidable parenteral nutritional use”, J Parenter Enteral Nutr, vol. 23, pp. 109-13, 1999.
, “Metabolic and monetary costs of avoidable parenteral nutrition use.”, JPEN J Parenter Enteral Nutr, vol. 23, no. 2, pp. 109-13, 1999.
, “Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccine.”, Vaccine, vol. 33, no. 41, pp. 5425-5431, 2015.
, “Myelodysplastic syndromes in the United States: an update for clinicians.”, Ann Med, vol. 46, no. 5, pp. 283-9, 2014.
, “Myelodysplastic Syndromes in the United States: An Update for Clinicians”, Ann Med, vol. 46, pp. 283-289, 2014.
, “Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy”, Matern Child Health J, vol. 26, no. 7, pp. 1488-1495, 2022.
, “Qualitative Results from NIDA Grant”, Maternal Child Health, vol. 26, no. 7, 2022.
, “Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.”, J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
, “Bupropion and Naltrexone in Methamphetamine Use Disorder”, N Engl J Med, vol. 384, no. 2, pp. 140-153, 2021.
, “Stimulant Reduction Intervention Using Dosed Exercise (STRIDE) - CTN 0037: Study Protocol for a Randomized Controlled Trial”, Trials, vol. 19, pp. 206-231, 2011.
, “Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: study protocol for a randomized controlled trial.”, Trials, vol. 12, p. 206, 2011.
, “Clinical trials referral resource. Current treatment trials for epithelial ovarian cancer.”, Oncology (Williston Park), vol. 19, no. 7, pp. 897-8, 900, 905-6 passim, 2005.
, “Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II)”, Oncology, vol. 15, pp. 601-3606-8
611, 2001.
, “Clinical Trials Referral Resource. Clinical trials in cervical cancer.”, Oncology (Williston Park), vol. 17, no. 1, pp. 84-9, 2003.
, “Clinical trials referral source. Current randomized phase III trials in gynecologic cancer.”, Oncology (Williston Park), vol. 18, no. 13, pp. 1642, 1645-6, 2004.
, “Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I)”, Oncology, vol. 15, pp. 456-861-6, 2001.
, “Clinical trials referral resource. Clinical trials in ovarian cancer, Part 2.”, Oncology (Williston Park), vol. 16, no. 12, pp. 1660-2, 1665-7, 2002.
, “Clinical trials referral resource. Current clinical trials investigating cancer in the elderly.”, Oncology (Williston Park), vol. 17, no. 12, pp. 1712-3, 1718-9, 2003.
, “Clinical trials referral resource. Current clinical trials in cervical cancer.”, Oncology (Williston Park), vol. 14, no. 7, pp. 1045-6, 1049-50, 2000.
, “Clinical trials referral resource. Clinical trials in ovarian cancer; Part 1.”, Oncology (Williston Park), vol. 16, no. 11, pp. 1498-9, 1504, 1506-7, 2002.
,